📰 Exosome Sciences News
Page 2 - Exosome Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exosome Sciences. Real-time updates on events, politics, business and more.
July 14, 2022
/PRNewswire/ -- According to the detailed analytical study of the exosomes diagnostic and therapeutics market, it is estimated at USD 58.6 million in 2022 and...
July 7, 2022
/PRNewswire/ -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and...
July 7, 2022
/PRNewswire/ -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and...
July 5, 2022
DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization" report has been added to ResearchAndMarkets.com's offering.Key Topics Covered:1 Molecular Dx Oncology Market - Strategic Situation Analysis with I...
June 8, 2022
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized...
March 28, 2022
/PRNewswire/ -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant...
March 28, 2022
/PRNewswire/ -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.coms...
February 15, 2022
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with...
February 9, 2022
/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19...
February 9, 2022
/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19...